We examined the inhibitory effects of novel triterpene glycoside compounds [ziyu-glycoside II (ZY-II) and its methyl ester (ZYM-201)], which originated from the roots of sanguisorba officinalis L. (Rosaceae), on tissue factor (TF) activity and tumor necrosis factor (TNF)-alpha production. In in vitro TF activity tests, ZY-II but not ZYM-201 strongly blocked lung TF activity with an IC50 value of 0.46 microM. By contrast, only ZYM-201 dose-dependently inhibited in vivo TF activity with an ED50 value of 1.7 mg/kg, when orally administered. Furthermore, ZYM-201 diminished both in vitro and in vivo TNF-alpha production with IC50 or ED50 values of 69.4 microM and 87.4 mg/kg, respectively. Therefore, these results suggest either that ZYM-201 may be developed as a potent inhibitor of both TF- and TNF-alpha-mediated diseases such as atherosclerosis and septic shock, or it may be a lead compound to be derivatized for further improvement of its curative efficacy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-2006-947257 | DOI Listing |
Vet Res Commun
November 2024
Laboratory of Pathology and Immunology of Aquatic Animals, School of Marine Life and Fisheries, Jiangsu Ocean University, Lianyungang, 222005, China.
Aeromonas veronii has emerged as a significant pathogen that impacts both fish and mammals. Recently, an infectious disease characterized by multiple ulcers on the body surface with a high mortality rate occurred in Channa argus cultured in Jiangsu Province, China. A Gram-negative bacterial strain (Aer12) was isolated from the body surface of the diseased fish and identified as A.
View Article and Find Full Text PDFFront Pharmacol
September 2024
Department of Cosmetic and Pharmaceutical Chemistry, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Introduction: L. is classified as a medicinal plant and used in traditional medicine. The root of this plant is mainly used as a medicinal raw material, but the above-ground parts are also a valuable source of health-promoting biologically active compounds.
View Article and Find Full Text PDFHeliyon
June 2024
School of Basic Medical Sciences, Southwest Medical University, Luzhou, 646000, China.
Phytomedicine
September 2024
School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, People's Republic of China. Electronic address:
Background: Osteosarcoma (OS), the most prevalent primary bone malignancy, exhibits rapid growth and a high tendency for lung metastasis, posing significant treatment challenges. Ziyuglycoside II (ZGS II), a main active compound derived from Sanguisorba officinalis l., has shown potential in cancer treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!